Antisense Therapeutics Limited

ASX:ANP.AX

0.058 (AUD) • At close January 3, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.

20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Omzet 1.581.7780.5780.6680.58700.06913.8640000006.3990.762000000
Kosten van de omzet 0.0330.0660.110.2040.138000000000000000000
Brutowinst 1.5471.7120.4670.4650.44900.06913.8640000006.3990.762000000
Brutowinstmarge 0.9790.9630.8090.6950.765011100000011000000
Onderzoek- en ontwikkelingskosten 10.1624.5354.9131.8991.7610.9751.1041.8481.6762.1461.5461.1150.6471.4881.8495.1323.3732.9874.4743.8233.7295.1320.235
Algemene en administratieve kosten 3.0542.9213.5564.4561.6791.4281.9751.90821.9461.9841.5631.6352.2332.5482.2871.5771.2891.2681.1821.5180.8060.022
Verkoop- en marketingkosten 1.3231.1420.8360.6280.37300000000.1470.1440.1940.092000.0950.04000.001
Verkoop-, algemene en administratieve kosten 3.0542.9213.5564.4561.6791.4281.9751.90821.9461.9841.5631.6352.2332.5482.2871.5771.2891.2681.1821.5180.8060.022
Overige kosten 1.5880.1550.2140.3110.1430.2640.3920.4260.6791.161.1040.9580.5310.3220.440.1670.2790.0760.2750.6680.0020.783-0.133
Bedrijfskosten 13.3457.6118.6836.6663.5832.623.2874.0723.8894.2563.7622.8612.4353.8714.5997.525.5985.9477.1356.3446.5686.7310.272
Bedrijfsresultaat -13.345-7.611-8.683-6.666-3.583-2.62-3.218-3.072-0.025-4.256-3.762-2.861-2.435-3.871-4.599-1.121-5.602-5.947-7.135-6.344-6.573-6.721-0.272
Bedrijfsresultaat ratio -8.447-4.281-15.029-9.973-6.1060-46.554-3.072-0.006000000-0.175-7.348000000
Totaal overige inkomsten en kosten netto 1.5881.7990.6230.7580.6390.2640.3920.4260.6791.161.1040.9580.5310.3220.440.1670.2790.0760.2750.668-0.0040.4-0.133
Inkomen voor belasting -11.38-5.812-8.061-5.908-2.944-2.331-2.755-2.5140.707-3.013-2.455-1.801-1.814-3.446-3.904-0.537-4.836-5.462-6.266-4.981-6.108-6.321-0.394
Inkomen voor belasting ratio -7.203-3.269-13.951-8.839-5.0180-39.858-2.5140.183000000-0.084-6.343000000
Belastingkosten -0.3770.0220.007-0.018-0.6390.289-0.071-0.132-0.052-0.083-0.203-0.102-0.091-0.021-1.2541.60.279-0.408-6.266-4.981-6.108-6.321-0.394
Nettowinst -11.38-5.834-8.067-5.89-2.306-2.331-2.755-2.5140.707-3.013-2.455-1.801-1.814-3.425-2.65-2.137-4.836-5.462-6.266-4.61-6.108-6.321-0.394
Nettowinstmarge -7.203-3.281-13.963-8.812-3.930-39.858-2.5140.183000000-0.334-6.343000000
WPA (Winst Per Aandeel) -0.018-0.009-0.015-0.013-0.006-0.012-0.017-0.0140.004-0.021-0.017-0.017-0.024-0.038-0.03-0.026-0.062-0.1-0.12-0.089-0.16-0.25-0.012
Verwaterde WPA -0.018-0.009-0.015-0.013-0.006-0.012-0.017-0.0140.004-0.021-0.017-0.017-0.024-0.038-0.03-0.026-0.062-0.1-0.12-0.089-0.16-0.25-0.012
EBITDA -13.25-7.522-8.58-6.559-3.578-2.614-3.213-3.067-0.017-4.246-3.754-2.854-2.429-3.864-4.591-1.112-4.375-4.492-5.837-5.045-4.805-5.634-0.271
EBITDA ratio -8.387-4.231-14.85-9.812-6.0970-46.484-3.067-0.004000000-0.174-5.739000000